Sector: Pharmaceuticals & Biotechnology

Small Cap

Rekvina Laboratories Share Price

Q: What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 20 May 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 21.2 Cr.

Q: What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -89.2, and the Price-to-Book (PB) ratio is -24.1.

Q: What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Q: Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Vivimed Labs for analysis and benchmarking.

Rekvina Laboratories Ltd.

₹38.27

1.82(4.99%)

Trade Now

25th May 2026 | 2:25 PM

NSE :

Open Free Demat Account

Rekvina Laboratories Performance

Price Movement

N/A

₹34.63

₹38.27

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹38.27

Low₹34.63

Open at₹36.45

Prev Close₹36.45

Volumes7.45 K

Avg Price₹37.04

Lower Circuit₹34.63

Upper Circuit₹38.27

Historical Performance

3M High₹46.65

3M Low₹23.63

1 Yr High₹46.65

1 Yr Low₹6.75

3 Yr High₹46.65

3 Yr Low₹6.75

5 Yr High₹46.65

5 Yr Low₹3.60

Rekvina Laboratories Fundamentals

Market Cap

Low in industry

21.20 Cr.

PE Ratio (TTM)

Negative PE TTM

-89.20

Dividend Yield

Net Profit TTM

140% decr over last year

-0.24

Net Profit Growth

140% decr over last year

-0.24

PEG Ratio

Above industry Median

0.60

ROE

Operating Revenue TTM

0.54

Operating Revenue Growth

Book Value

Negative Price to Book

-24.10

MFI

MFI Overbought

72.15

RSI

RSI is mid-range

38.53

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-24.10

Rekvina Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0.35	0.20	0	0	0
Operating Expense	0.47	0.23	0.04	0.04	0.02
Operating Profit	-0.12	-0.03	-0.04	-0.04	-0.02
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0	0	0
Net Profit	-0.12	-0.03	-0.04	-0.04	-0.02

Rekvina Laboratories Technicals

Rekvina Laboratories Ltd. EMA & SMA

₹38.27

1.34 (3.63%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹37.2

Day EMA10 ₹38.3

Day EMA12 ₹38.6

Day EMA20 ₹39.2

Day EMA26 ₹39

Day EMA50 ₹36

Day EMA100 ₹28.7

Day EMA200 ₹20.6

Rekvina Laboratories Support and Resistance

Resistance

First Resistance₹35.09

Second Resistance₹35.09

Third Resistance₹35.09

Support

First Support₹35.09

Second Support₹35.09

Third Support₹35.09

Technical Indicators

Day RSI38.53

Day MFI72.15

Day ADX40.56

Day Commodity Channel Index-128.60

William-84.64

Day MACD-0.38

Day MACD Signal Line0.52

Day ATR1.45

Day ROC125588.04

Day ROC21-20.23

Rekvina Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	41.3	41.3	41.3	41.3	41.3	41.3
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	58.7	58.7	58.7	58.7	58.7	58.7

Rekvina Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2.07 K	2.07 K	100.00%
Week	3.59 K	3.59 K	100.00%
1 Month	4.19 K	4.19 K	100.00%
6 Month	4.03 K	4.03 K	100.00%

Rekvina Laboratories SWOT Analysis

Strengths8

Weakness10

Opportunity1

Threats0

Consistent high performing stocks over Five Years

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Increasing Revenue every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Stocks Outperforming their Industry Price Change in the Quarter

Rekvina Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Rekvina Laboratories Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Vivimed Labs Ltd.
Price (₹)	₹46.26	₹492.90	₹219.30	₹252.10	₹6.40
% Change	-4.99%	1.27%	4.95%	-4.14%	-2.14%
Revenue TTM (₹ Cr)	-	-	-	-	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-34.95
PE TTM	18.30	-	23.60	37.60	-1.50
1 Year Return		22.61			551
ROCE	-	28.91	-	-	-5.63

Similar Stocks

CURIS

Curis Lifesciences Ltd.

₹ 122.00

-1.61%

APPL

Aptus Pharma Ltd.

₹ 179.50

-1.37%

AMANTA

Amanta Healthcare Ltd.

₹ 131.01

+0.71%

AHCL

Anlon Healthcare Ltd.

₹ 13.79

-0.86%

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.65

+7.67%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 87.00

-4.05%

APL

Asston Pharmaceuticals Ltd.

₹ 72.80

+0.00%

INFLUX

Influx Healthtech Ltd.

₹ 236.10

-5.48%

MEDIORG

Medicamen Organics Ltd.

₹ 24.00

-1.84%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 559.75

+0.46%

ASTONEALAB

Astonea Labs Ltd.

₹ 231.00

+1.76%

AMWILL

Amwill Health Care Ltd.

₹ 32.38

+4.96%

INNOVACAP

Innova Captab Ltd.

₹ 852.80

+0.53%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 78.00

+1.46%

SHELTER

Shelter Pharma Ltd.

₹ 30.63

-0.07%

TLL

Trident Lifeline Ltd.

₹ 254.00

+2.13%

DPL

Dipna Pharmachem Ltd.

₹ 7.47

-0.66%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.83

+2.64%

SIGACHI

Sigachi Industries Ltd.

₹ 20.34

-0.05%

WINDLAS

Windlas Biotech Ltd.

₹ 784.40

-0.70%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 40.00

+5.26%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 556.00

+1.44%

FAQ's on VINRKLB

What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 20 May 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 21.2 Cr.

What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -89.2, and the Price-to-Book (PB) ratio is -24.1.

What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy